This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The General Hospital Corporation, General Electric Company. Active years: 2009-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Roxbury, MA (US) (2016)
- Ann Arbor, MI (US) (2009 - 2018)
Company Filing History:


Years Active: 2009-2018
Sure, here is the article about inventor Yongqing Li:
Title: The Innovative Work of Inventor Yongqing Li
Introduction:
Yongqing Li is a talented inventor based in Ann Arbor, MI, who has made significant contributions to the field of medical treatments through his innovative patented technologies.
Latest Patents:
Yongqing Li holds 3 patents, including groundbreaking inventions such as the treatment of sepsis and septic shock. This technology involves administering an agent that reduces the level of circulating citrullated histones, offering new hope in combating these life-threatening conditions. Additionally, Li's work on biomarkers of hemorrhagic shock utilizes a range of markers for diagnosis, prognosis, and treatment monitoring in cases of HS.
Career Highlights:
Having worked at esteemed institutions like The General Hospital Corporation and General Electric Company, Yongqing Li has honed his skills and expertise in the medical and technological sectors. His dedication to pushing boundaries and seeking new solutions to critical health issues is evident in his patent portfolio.
Collaborations:
Throughout his career, Li has collaborated with respected colleagues such as Hasan B Alam and Kevin George Harding. These partnerships have further enriched his research and enabled the development of innovative technologies that have the potential to save lives and improve patient outcomes.
Conclusion:
Inventor Yongqing Li's impactful work in the healthcare industry showcases his commitment to innovation and improving medical treatments. His patents stand as a testament to his dedication to advancing the field and addressing pressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile